CoChat

Sleep Disturbances in Patients with Schizophrenia: Impact and Effect of Antipsychotics

Cohrs, Stefan · 2008 · CNS Drugs

The DOI matches its Crossref record; 148 of the 149 references it cites were found in a registry or an index.

Abstract

Difficulties initiating or maintaining sleep are frequently encountered in patients with schizophrenia. Disturbed sleep can be found in 30-80% of schizophrenic patients, depending on the degree of psychotic symptomatology. Measured by polysomnography, reduced sleep efficiency and total sleep time, as well as increased sleep latency, are found in most patients with schizophrenia and appear to be an important part of the pathophysiology of this disorder. Some studies also reported alterations of stage 2 sleep, slow-wave sleep (SWS) and rapid eye movement (REM) sleep variables, i.e. reduced REM latency and REM density. A number of sleep parameters, such as the amount of SWS and the REM latency, are significantly correlated to clinical variables, including severity of illness, positive symptoms, negative symptoms, outcome, neurocognitive impairment and brain structure.Concerning specific sleep disorders, there is some evidence that schizophrenic patients carry a higher risk of experiencing a sleep-related breathing disorder, especially those demonstrating the known risk factors, including being overweight but also long-term use of antipsychotics. However, it is still unclear whether periodic leg movements in sleep or restless legs syndrome (RLS) are found with a higher or lower prevalence in schizophrenic patients than in healthy controls.There are no consistent effects of first-generation antipsychotics on measures of sleep continuity and sleep structure, including the percentage of sleep stages or sleep and REM latency in healthy controls. In contrast to first-generation antipsychotics, the studied atypical antipsychotics (clozapine, olanzapine, quetiapine, risperidone, ziprasidone and paliperidone) demonstrate a relatively consistent effect on measures of sleep continuity, with an increase in either total sleep time (TST) or sleep efficiency, and individually varying effects on other sleep parameters, such as an increase in REM latency observed for olanzapine, quetiapine and ziprasidone, and an increase in SWS documented for olanzapine and ziprasidone in healthy subjects.The treatment of schizophrenic patients with first-generation antipsychotics is consistently associated with an increase in TST and sleep efficiency, and mostly an increase in REM latency, whereas the influence on specific sleep stages is more variable. On the other hand, withdrawal of such treatment is followed by a change in sleep structure mainly in the opposite direction, indicating a deterioration of sleep quality. On the background of the rather inconsistent effects of first-generation antipsychotics observed in healthy subjects, it appears possible that the high-potency drugs exert their effects on sleep in schizophrenic patients, for the most part, in an indirect way by suppressing stressful psychotic symptomatology. In contrast, the available data concerning second-generation antipsychotics (clozapine, olanzapine, risperidone and paliperidone) demonstrate a relatively consistent effect on measures of sleep continuity in patients and healthy subjects, with an increase in TST and sleep efficiency or a decrease in wakefulness. Additionally, clozapine and olanzapine demonstrate comparable influences on other sleep variables, such as SWS or REM density, in controls and schizophrenic patients. Possibly, the effects of second-generation antipsychotics observed on sleep in healthy subjects and schizophrenic patients might involve the action of these drugs on symptomatology, such as depression, cognitive impairment, and negative and positive symptoms.Specific sleep disorders, such as RLS, sleep-related breathing disorders, night-eating syndrome, somnambulism and rhythm disorders have been described as possible adverse effects of antipsychotics and should be considered in the differential diagnosis of disturbed or unrestful sleep in this population.

Overview

Integrity signals

Registry

Crossref · 10.2165/00023210-200822110-00004

Cites

148 of 148 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 148 references

Research works printed but not linked: 13

  1. Donlon, 1975, Dis Nerv Syst Jun, 36, 323
  2. Royuela, 2002, Neurobiol Sleep Wakefulness Cycle, 2, 37
  3. Navarro, 1998, Psicologia Conductal, 6, 49
  4. Keshavan, 1990, Sleep Res, 19, 330
  5. Overall, 1962, Psychol Rep, 10, 779
  6. Rotenberg, 1997, Homeostasis, 38, 97
  7. Benson, 1994, Am Psychiatr Assoc Rev Psychiatry, 13, 677
  8. Neeper, 1992, Sleep Res, 21, 154
  9. Gillin, 1977, Commun Psychopharmacol, 1, 225
  10. Toyoda, 1964, Folia Psychiatr Neurol Jpn, 18, 198
  11. Cohrs, 2004, Psychopharmacol (Berl), 174, 421
  12. Ruther, 1976, Arzneimittelforschung, 26, 1071
  13. Huapaya, 1976, Am J Psychiatry, 133, 1207

Cited by

See all 454

Metadata

Authors
Cohrs, S.
Affiliations
University of Göttingen (DE)
Corresponding author
Cohrs, Stefan
Venue
CNS Drugs
Published
2008
Volume
22
Issue
11
Pages
939-962
ISSN
1172-7047 (ISSN-L)
OpenAlex
W2183656574
Cited by
433
References
149
Citations by year
2026: 19 · 2025: 19 · 2024: 23 · 2023: 24 · 2022: 29 · 2021: 25 · 2020: 29 · 2019: 27 · 2018: 24 · 2017: 35 · 2016: 37 · 2015: 31 · 2014: 16 · 2013: 32 · 2012: 20
FWCI
1.62
Type
journal article
Language
en
Open access
closed
Locations
  • CNS Drugs (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
Keywords
schizophrenia, sleep disorders, sleep efficiency, sleep latency, REM sleep, slow-wave sleep, REM latency, atypical antipsychotics, typical antipsychotics, sleep-disordered breathing, periodic limb movements in sleep, restless legs syndrome, antipsychotic withdrawal, sleep quality, polysomnography, neurocognitive impairment, positive and negative symptoms
MeSH terms
Humans, Schizophrenia, Sleep, Sleep Wake Disorders, Antipsychotic Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sleep Disturbances in Patients with Schizophrenia: Impact and Effect of Antipsychotics. https://app.cochat.ai/papers/10.2165/00023210-200822110-00004
The paper
Cohrs, S. (2008). Sleep Disturbances in Patients with Schizophrenia: Impact and Effect of Antipsychotics. CNS Drugs. https://doi.org/10.2165/00023210-200822110-00004

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.